Flynn James E 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-03 4:58 pm Sale | 2023-05-03 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 0 0.000% | -2,032,335 (Position Closed) | Filing |
| 2023-02-10 09:34 am Unchanged | 2022-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 2,032,335 5.510% | 0 (Unchanged) | Filing |
| 2022-09-12 5:23 pm Sale | 2022-09-08 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 2,032,335 5.530% | -1,250,577 (-38.09%) | Filing |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 3,282,912 10.720% | -166,000 (-4.81%) | Filing |